KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Amortization of Deferred Charges (2016 - 2018)

Historic Amortization of Deferred Charges for CareDx (CDNA) over the last 5 years, with Q4 2018 value amounting to $44000.0.

  • CareDx's Amortization of Deferred Charges fell 9352.94% to $44000.0 in Q4 2018 from the same period last year, while for Dec 2019 it was $100000.0, marking a year-over-year decrease of 9551.97%. This contributed to the annual value of $2.2 million for FY2018, which is 3534.18% down from last year.
  • CareDx's Amortization of Deferred Charges amounted to $44000.0 in Q4 2018, which was down 9352.94% from $56000.0 recorded in Q3 2018.
  • In the past 5 years, CareDx's Amortization of Deferred Charges registered a high of $2.1 million during Q1 2018, and its lowest value of -$455000.0 during Q4 2016.
  • Over the past 5 years, CareDx's median Amortization of Deferred Charges value was $104500.0 (recorded in 2014), while the average stood at $331450.0.
  • As far as peak fluctuations go, CareDx's Amortization of Deferred Charges tumbled by 115813.95% in 2016, and later surged by 751333.33% in 2017.
  • CareDx's Amortization of Deferred Charges (Quarter) stood at $7000.0 in 2014, then surged by 514.29% to $43000.0 in 2015, then crashed by 1158.14% to -$455000.0 in 2016, then surged by 249.45% to $680000.0 in 2017, then crashed by 93.53% to $44000.0 in 2018.
  • Its Amortization of Deferred Charges stands at $44000.0 for Q4 2018, versus $56000.0 for Q3 2018 and $48000.0 for Q2 2018.